Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres

Phillips, Bob; Selwood, Karen; Lane, Sheila M.; Skinner, Roderick; Gibson, Faith; Chisholm, Julia C.
June 2007
Archives of Disease in Childhood;Jun2007, Vol. 92 Issue 6, p495
Academic Journal
Objective: To assess the variation in the current UK management strategies for the treatment of febrile neutropenia in childhood. Design and setting: A postal survey of all 21 United Kingdom Children's Cancer Study Group (UKCCSG) centres assessing and collating local policies, protocols or guidelines relating to the management of febrile neutropenia. Further direct contact was undertaken to clarify any uncertainties. Results: All 21 centres provided information. The policies used to manage febrile neutropenia in the centres around the UK vary in almost every aspect of management. Definitions of fever ranged from a persistent temperature of >37.5°C to a single reading of >39°C. Neutropenia was inconsistently defined as an absolute neutrophil count of <1 ×109, <0.75×109 or <0.5×109. Choices of antibiotic approaches, empirical modifications and antistaphylococcal treatment were different in each protocol. The use of risk stratification was undertaken in 11 centres, with six using a policy of reduced intensity therapy in low risk cases. Empirical antifungal treatment was very poorly described and varied even more widely. Conclusions: There was a great deal of variation in definitions and treatment of febrile neutropenia in the UKCCSG children's cancer treatment centres. A degree of variation as a result of local microbiological differences is to be expected, but beyond this we should seek to standardise the core of our approach to defining fever and neutropenia, risk stratification and duration of empirical therapy in a way that maintains safety, minimises resource utilisation and maximises quality of life.


Related Articles

  • Recurrent Febrile Infections and Neutropenia in a Child With Silent Celiac Disease. Leonardi, Salvatore; Vitaliti, Giovanna; La Rosa, Mario // Clinical Pediatrics;Feb2010, Vol. 49 Issue 2, p146 

    Backgound. Today it is known that celiac disease (CD) may be silent or present with atypical extraintestinal symptoms (silent/atypical CD). Case report. The authors report the case of a 3-year-old child in whom the diagnosis of CD was made after several admissions to hospital for recurrent...

  • Supportive care: managing febrile neutropenia. Hawkins, Jeanette // Paediatric Nursing;May2009, Vol. 21 Issue 4, p33 

    Chemotherapy, the most commonly used treatment for childhood cancer, can have a devastating effect on the immune system, reducing defenses against infection, particularly bacterial infection, a common cause of life-threatening sepsis. Before they leave hospital for the first time after...

  • Cyclophosphamide/doxorubicin.  // Reactions Weekly;3/12/2011, Issue 1342, p13 

    The article describes the case of a 55-year-old woman who acquired febrile neutropenia due to treatment with cyclophosphamide and doxorubicin.

  • Controlled Trials of Amphotericin B Lipid Complex. Boyle, James A. // Clinical Infectious Diseases;10/1/2000, Vol. 31 Issue 4, p1117 

    Focuses on the use of amphotericin B lipid complex (ABLC) and other lipid-associated formulations as therapy for febrile neutropenia. Treatment using Abelcet in patients who have developed intolerance to amphotericin B.

  • Home IV antibiotics cost-effective measure for managing children with febrile neutropenia.  // Infectious Diseases in Children;Mar2011, Vol. 24 Issue 3, p44 

    The article discusses a research study which showed that home intravenous antibiotics for febrile neutropenia in children with cancer is neither cost-effective nor preferred by patients, published in a 2011 online issue of the journal "Pediatrics."

  • Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy--a representative sample survey in Germany. Link, Hartmut; Nietsch, J.; Kerkmann, M.; Ortner, P.; Supportive Care Group (ASORS) of the German Cancer Society (DKG) // Supportive Care in Cancer;Jan2016, Vol. 24 Issue 1, p367 

    Purpose: Febrile neutropenia (FN) after chemotherapy increases complications, morbidity, risk of death, reduction of dose delivery and impairs quality of life. Primary granulocyte-colony stimulating factor (G-CSF) prophylaxis after chemotherapy is recommended in the guideline (GL)...

  • Tratamiento antimicrobiano en niños con neutropenia febril de alto riesgo. MUÑOZ B., ELIANA; OSSA A., JUAN CRISTÓBAL; VILLARROEL C., MILENA; SANTOLAYA D. P., MARÍA ELENA // Revista Chilena de Pediatría;jul-ago2008, Vol. 79 Issue 4, p381 

    Background: In children with cancer and high risk febrile neutropenia (HRFN), the initial empirical treatment used in our hospital for 5 years includes the association of Cloxacillin + Ceftazidime + Amikacin. There is no chilean literature that reviews the effectiveness of this therapy...

  • Randomized Controlled Trial of Once- Versus Thrice-Daily Tobramycin in Febrile Neutropenic Children Undergoing Stem Cell Transplantation. Sung, Lillian; Dupuis, L. Lee; Bliss, Bonnie; Taddio, Anna; Abdolell, Mohamed; Allen, Upton; Rolland, Martha; Tong, Agnes; Taylor, Tracey; Doyle, John // JNCI: Journal of the National Cancer Institute;12/17/2003, Vol. 95 Issue 24, p1869 

    Background: The benefits of aminoglycoside antibiotics, such as tobramycin, administered as a once-daily dose to manage febrile neutropenia, have been demonstrated in many patient populations. However, toxicity and safety data are lacking for pediatric stem cell transplant recipients, who are at...

  • Febrile Neutropenia in the Emergency Department: "Guideline? We Don't Need No Stinkin' Guideline".  // Clinical Infectious Diseases;2/1/2017, Vol. 64 Issue 3, piii 

    An abstract of the article "ED management of patients with febrile neutropenia: guideline concordant or overly aggressive?" by CW. Baugh, TJ. Wang and JM. Caterino is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics